These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11554335)

  • 21. Biomedicine. Defining the "S" in SERMs.
    Katzenellenbogen BS; Katzenellenbogen JA
    Science; 2002 Mar; 295(5564):2380-1. PubMed ID: 11923515
    [No Abstract]   [Full Text] [Related]  

  • 22. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
    Lewis JS; Jordan VC
    Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen receptor ligands. Part 13: Dihydrobenzoxathiin SERAMs with an optimized antagonist side chain.
    Blizzard TA; DiNinno F; Chen HY; Kim S; Wu JY; Chan W; Birzin ET; Yang YT; Pai LY; Hayes EC; DaSilva CA; Rohrer SP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3912-6. PubMed ID: 15993065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-based approach for the discovery of novel selective estrogen receptor modulators.
    Rosano C; Stec-Martyna E; Lappano R; Maggiolini M
    Curr Med Chem; 2011; 18(8):1188-94. PubMed ID: 21291367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular simulation of interaction between estrogen receptor and selective estrogen receptor modulators.
    Guo ZR; Yi X; Xu ZB
    Acta Pharmacol Sin; 2002 Mar; 23(3):208-12. PubMed ID: 11918843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents.
    Jordan VC
    J Med Chem; 2003 Mar; 46(7):1081-111. PubMed ID: 12646017
    [No Abstract]   [Full Text] [Related]  

  • 27. [Selective estrogen receptor modulators].
    Holzgrabe U
    Pharm Unserer Zeit; 2004; 33(5):357-9. PubMed ID: 15497329
    [No Abstract]   [Full Text] [Related]  

  • 28. Tamoxifen, raloxifene and the prevention of breast cancer.
    Bentrem DJ; Craig Jordan V
    Minerva Endocrinol; 2002 Jun; 27(2):127-39. PubMed ID: 11961504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On-line formation, separation, and estrogen receptor affinity screening of cytochrome P450-derived metabolites of selective estrogen receptor modulators.
    van Liempd SM; Kool J; Niessen WM; van Elswijk DE; Irth H; Vermeulen NP
    Drug Metab Dispos; 2006 Sep; 34(9):1640-9. PubMed ID: 16790557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and structure-activity relationships of chromene-derived selective estrogen receptor modulators for treatment of postmenopausal symptoms.
    Jain N; Xu J; Kanojia RM; Du F; Jian-Zhong G; Pacia E; Lai MT; Musto A; Allan G; Reuman M; Li X; Hahn D; Cousineau M; Peng S; Ritchie D; Russell R; Lundeen S; Sui Z
    J Med Chem; 2009 Dec; 52(23):7544-69. PubMed ID: 19366247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia.
    Norman BH; Dodge JA; Richardson TI; Borromeo PS; Lugar CW; Jones SA; Chen K; Wang Y; Durst GL; Barr RJ; Montrose-Rafizadeh C; Osborne HE; Amos RM; Guo S; Boodhoo A; Krishnan V
    J Med Chem; 2006 Oct; 49(21):6155-7. PubMed ID: 17034120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions.
    Jordan VC
    J Med Chem; 2003 Mar; 46(6):883-908. PubMed ID: 12620065
    [No Abstract]   [Full Text] [Related]  

  • 33. Physicochemical properties of tamoxifen hemicitrate sesquihydrate.
    Kojima T; Katoh F; Matsuda Y; Teraoka R; Kitagawa S
    Int J Pharm; 2008 Mar; 352(1-2):146-51. PubMed ID: 18061380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, binding and structure-affinity studies of new ligands for the microsomal anti-estrogen binding site (AEBS).
    Poirot M; De Medina P; Delarue F; Perie JJ; Klaebe A; Faye JC
    Bioorg Med Chem; 2000 Aug; 8(8):2007-16. PubMed ID: 11003145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 3: synthesis of cyclopentanone and cyclohexanone intermediates for C-ring modification.
    Richardson TI; Dodge JA; Durst GL; Pfeifer LA; Shah J; Wang Y; Durbin JD; Krishnan V; Norman BH
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4824-8. PubMed ID: 17614275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 2: structure-activity relationship studies on the benzopyran scaffold.
    Richardson TI; Norman BH; Lugar CW; Jones SA; Wang Y; Durbin JD; Krishnan V; Dodge JA
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3570-4. PubMed ID: 17485205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetrahydroquinoline-based selective estrogen receptor modulators (SERMs).
    Wallace OB; Lauwers KS; Jones SA; Dodge JA
    Bioorg Med Chem Lett; 2003 Jun; 13(11):1907-10. PubMed ID: 12749895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzothiophenes containing a piperazine side chain as selective ligands for the estrogen receptor alpha and their bioactivities in vivo.
    Yang C; Xu G; Li J; Wu X; Liu B; Yan X; Wang M; Xie Y
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1505-7. PubMed ID: 15713417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective estrogen-receptor modulators and antihormonal resistance in breast cancer.
    Jordan VC; O'Malley BW
    J Clin Oncol; 2007 Dec; 25(36):5815-24. PubMed ID: 17893378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medicinal Chemistry--13th RSC-SCI Symposium.
    Herrick V
    IDrugs; 2005 Nov; 8(11):901-3. PubMed ID: 16254781
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.